Sulfated polymannuroguluronate, a novel anti-acquired immune deficiency syndrome drug candidate, blocks neuroinflammatory signalling by targeting the transactivator of transcription (Tat) protein.
- 浏览0
Journal of Neurochemistry
334-344页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



